Compare IE & ARDX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | IE | ARDX |
|---|---|---|
| Founded | 2020 | 2007 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Metal Mining | Biotechnology: Pharmaceutical Preparations |
| Sector | Basic Materials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.4B | 1.3B |
| IPO Year | 2022 | 2014 |
| Metric | IE | ARDX |
|---|---|---|
| Price | $8.08 | $5.09 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 3 | 7 |
| Target Price | ★ $18.17 | $15.14 |
| AVG Volume (30 Days) | 2.4M | ★ 4.7M |
| Earning Date | 05-06-2026 | 04-30-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $3,244,000.00 | $2,607,000.00 |
| Revenue This Year | $44.79 | $37.75 |
| Revenue Next Year | $16.22 | $34.24 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | ★ 11.82 | N/A |
| 52 Week Low | $7.90 | $4.08 |
| 52 Week High | $21.55 | $8.40 |
| Indicator | IE | ARDX |
|---|---|---|
| Relative Strength Index (RSI) | 29.31 | 38.21 |
| Support Level | N/A | $4.89 |
| Resistance Level | $10.15 | $5.34 |
| Average True Range (ATR) | 0.53 | 0.21 |
| MACD | -0.01 | -0.01 |
| Stochastic Oscillator | 11.14 | 30.40 |
Ivanhoe Electric Inc is a United States-based d minerals exploration company with a focus on developing mines from mineral deposits principally located in the United States. The company has four business segments; Santa Cruz Project; critical metals; data processing services; and energy storage. It derives a majority of its revenue from Canada. The Santa Cruz Project and critical metals segments are focused on mineral project exploration and development. The data processing segment provides data analytics, geophysical modeling, and artificial intelligence services for the mineral, oil & gas, and water exploration industries. The energy storage segment develops, manufactures, and installs vanadium flow batteries for grid-scale energy storage.
Ardelyx Inc is a biopharmaceutical company developing and commercialize, first-in-class medicines that meet unmet medical needs. It has developed a platform that enabled the discovery of new biological mechanisms and pathways to develop potent and efficacious therapies that minimize the side effects and drug-drug interactions frequently encountered with traditional, systemically absorbed medicines. Its products Tenapanor, branded as IBSRELA, is used for the treatment of adults with IBS-C. Tenapanor, branded as XPHOZAH, is used to reduce serum phosphorus in adults with CKD on dialysis as add-on therapy in patients who have an inadequate response to phosphate binders or who are intolerant of any dose of phosphate binder therapy.